These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8764316)

  • 1. Antisense oligodeoxynucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury.
    Peresleni T; Noiri E; Bahou WF; Goligorsky MS
    Am J Physiol; 1996 Jun; 270(6 Pt 2):F971-7. PubMed ID: 8764316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of antisense oligodeoxynucleotides on nitric oxide secretion from macrophage-like cells.
    Bilecki W; Okruszek A; Przewłocki R
    Antisense Nucleic Acid Drug Dev; 1997 Dec; 7(6):531-7. PubMed ID: 9450910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of methylcholanthrene-induced neoplastic transformation in murine C3H 10T1/2 fibroblasts by antisense phosphorothioate oligodeoxynucleotide sequences.
    Lesoon-Wood LA; Pierce LM; Lau AF; Cooney RV
    Cancer Lett; 1999 Dec; 147(1-2):163-73. PubMed ID: 10660102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of nitric oxide production in macrophages by phosphorothioate antisense oligonucleotides.
    Arima H; Sakamoto T; Aramaki Y; Ishidate K; Tsuchiya S
    J Pharm Sci; 1997 Oct; 86(10):1079-84. PubMed ID: 9344161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide is necessary for a switch from stationary to locomoting phenotype in epithelial cells.
    Noiri E; Peresleni T; Srivastava N; Weber P; Bahou WF; Peunova N; Goligorsky MS
    Am J Physiol; 1996 Mar; 270(3 Pt 1):C794-802. PubMed ID: 8638659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia.
    Noiri E; Peresleni T; Miller F; Goligorsky MS
    J Clin Invest; 1996 May; 97(10):2377-83. PubMed ID: 8636419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C; Calabretta B
    Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice.
    Ding M; Zhang M; Wong JL; Rogers NE; Ignarro LJ; Voskuhl RR
    J Immunol; 1998 Mar; 160(6):2560-4. PubMed ID: 9510151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching off HSP70 and i-NOS to study their role in normal and H2O2-stressed human fibroblasts.
    Renis M; Cardile V; Grasso S; Palumbo M; Scifo C
    Life Sci; 2003 Dec; 74(6):757-69. PubMed ID: 14654168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense blockade of inducible nitric oxide synthase in glial cells derived from adult SJL mice.
    Ding M; Zhang M; Wong JL; Voskuhl RR; Ellison GW
    Neurosci Lett; 1996 Dec; 220(2):89-92. PubMed ID: 8981480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligodeoxynucleotide to inducible nitric oxide synthase inhibits nitric oxide synthesis in rat pulmonary artery smooth muscle cells in culture.
    Thomae KR; Geller DA; Billiar TR; Davies P; Pitt BR; Simmons RL; Nakayama DK
    Surgery; 1993 Aug; 114(2):272-7. PubMed ID: 7688152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human renal epithelial cells express iNOS in response to cytokines but not bacteria.
    Poljakovic M; Karpman D; Svanborg C; Persson K
    Kidney Int; 2002 Feb; 61(2):444-55. PubMed ID: 11849384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of myocardial SOD and iNOS during ischemia-reperfusion by antisense directed at ACE mRNA.
    Mehta JL; Chen H; Li D; Phillips IM
    J Mol Cell Cardiol; 2000 Dec; 32(12):2259-68. PubMed ID: 11113001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells.
    Binder C; Schulz M; Hiddemann W; Oellerich M
    Lab Invest; 1999 Dec; 79(12):1703-12. PubMed ID: 10616218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased nitric oxide synthase activity as a cause of mitochondrial dysfunction in rat hepatocytes: roles for tumor necrosis factor alpha.
    Kurose I; Miura S; Higuchi H; Watanabe N; Kamegaya Y; Takaishi M; Tomita K; Fukumura D; Kato S; Ishii H
    Hepatology; 1996 Nov; 24(5):1185-92. PubMed ID: 8903396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
    Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
    Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligodeoxynucleotides to human inducible nitric oxide synthase selectively inhibit induced nitric oxide production by human vascular endothelial cells: an experimental study.
    Tanjoh K; Tomita R; Hayashi N
    Eur J Surg; 2000 Nov; 166(11):882-7. PubMed ID: 11097156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
    Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication.
    Lavigne C; Yelle J; Sauvé G; Thierry AG
    AAPS PharmSci; 2001; 3(1):E7. PubMed ID: 11741258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice.
    Han DC; Hoffman BB; Hong SW; Guo J; Ziyadeh FN
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F628-34. PubMed ID: 10751224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.